2nd Annual Congress on

Midwifery and Women's Health

Women's Health 2024

Theme: Caring the Journey from Womb to the World

2nd Annual Congress on Midwifery and Women`s Health will be held during October 22-23, 2024 in Paris, France. It is going to host healthcare professionals, practitioners, and trainers from the government as well as private sectors with years of experience in this field along with students and recent graduates. At the Midwifery Conference, eminent keynote speakers along with the young fellows will showcase their research in the form of oral and poster presentations along with questionnaires and networking sessions. This time Women Health 2024 will be primarily focusing on the theme “Caring the Journey from Womb to the Worldwith an aim to make a convergence of connoisseurs so that we can bridge up the gap between labs and research centers with the day-to-day issues patients are facing
Session 1Reproductive health
Reproductive health refers to the state of well-being in all aspects of the reproductive system, encompassing both physical and mental health. It involves access to comprehensive healthcare services that address family planning, safe pregnancies, and the prevention and management of reproductive disorders.
Hormone Replacement Therapy (HRT) involves administering hormones to alleviate symptoms associated with hormonal deficiencies, commonly used in menopause. It often includes estrogen and progesterone for women experiencing symptoms like hot flashes and mood changes.
Session 3Women's oncology
Women's oncology is a specialized field focusing on the prevention, diagnosis, and treatment of cancers specific to women, including breast, ovarian, cervical, and uterine cancers. Comprehensive care in women's oncology involves a multidisciplinary approach, incorporating surgery, chemotherapy, radiation therapy, and targeted therapies tailored to each patient's unique needs.
The menstrual cycle is a natural process in which the female body undergoes hormonal fluctuations, leading to the shedding of the uterine lining, commonly known as menstruation. Menopause marks the end of the reproductive years, typically occurring in a woman's late 40s or early 50s, resulting in the cessation of menstrual cycles due to declining hormone levels.
The effects of drugs on pregnancy vary, and some medications may pose risks to the developing fetus. It is crucial for pregnant individuals to consult healthcare professionals before taking any medication to ensure the safety of both the mother and the baby.
Research generally indicates that the majority of women do not experience negative mental health effects after an abortion. Factors such as pre-existing mental health conditions, social support, and the decision-making process play roles in post-abortion well-being.
Mother and child care encompasses healthcare services and support tailored to the needs of pregnant women, mothers, and newborns. It involves prenatal care to ensure a healthy pregnancy, safe delivery practices, and postpartum care for both the mother and the infant.
Gynecology focuses on the health of the female reproductive system, addressing issues such as menstrual disorders, infertility, and gynecological cancers. Obstetrics, on the other hand, specializes in pregnancy and childbirth, ensuring maternal and fetal well-being throughout the prenatal, delivery, and postpartum periods.
Breastfeeding is associated with various health benefits for both the mother and the infant, providing essential nutrients and fostering bonding. Studies suggest that breastfeeding may reduce the risk of breast cancer in mothers, offering a protective effect. The act of breastfeeding, along with its potential long-term health advantages, underscores the importance of promoting and supporting breastfeeding practices as part of maternal and infant care
Pregnancy involves a series of physiological changes, and comprehensive prenatal care is crucial for monitoring the health of both the mother and the developing fetus. This care includes regular check-ups, ultrasounds, and educational support to ensure a healthy pregnancy.
Session 11Infertility and Art
Infertility refers to the inability to conceive after a year of regular unprotected intercourse, impacting many couples worldwide. Assisted Reproductive Technology (ART) encompasses various medical interventions, such as in vitro fertilization (IVF) and fertility medications, to aid in achieving pregnancy for couples facing infertility challenges.
Session 12 PCOD and PCOS
Polycystic Ovary Syndrome (PCOS) is a common hormonal disorder affecting people with ovaries, characterized by irregular menstrual cycles, elevated androgen levels, and the presence of cysts on the ovaries. Polycystic Ovary Disease (PCOD) is a broader term often used interchangeably with PCOS, encompassing a range of symptoms related to ovarian dysfunction.
The global women’s health market size was valued at USD 38.11 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 4.8% from 2022 to 2030. Market growth can be attributed to the increase in the women geriatric population and the introduction of new products for women’s health, such as Relugoliz and Orilissa among others. Furthermore, favorable policies initiated by governments to improve women’s health and raise awareness are likely to drive the market over the forecast period. Access to contraception and gynecological testing declined, raising the rate of unsafe abortions and unwanted pregnancies, especially in developing countries. For instance, according to the BMC, in the low- and middle-income countries, there has been around a 10% decline in the use of long- and short-acting reversible contraceptives, about 10% decline in essential services related to pregnancy care. All these factors led to a decline in market growth amid the pandemic. Women are more susceptible to various diseases, such as osteoporosis, osteoarthritis, endometriosis, and menstrual health disorders.

                                                                                    

                                 

Around 73% of postmenopausal women experience hot flashes, fatigue, and sleep disturbances, which increase dependence on medications, impairing the quality of life. With aging and the increasing prevalence of obesity, the cases of osteoporosis are anticipated to grow. Some of the major factors leading to hormonal imbalance in women are stress, change in dietary habits, and alcohol consumption, which further cause fertility issues. Polycystic Ovarian Syndrome (PCOS), ovulation problems, and endometriosis are some of the major causes of infertility. According to the WHO, in 2021, globally, around 190 million women of reproductive age were affected by endometriosis.
These factors are anticipated to fuel the market growth. According to the United Nations, the Department of Social and Economic Affairs, approximately 1.1 billion women needed family planning in 2019, out of which, 190 million had unmet contraception needs and about 842 million used modern methods of contraception. Owing to the high unmet need for publicly-funded contraceptive services and products, federal & state governments are actively working toward improving family planning services and improving access to modern contraceptives.
For instance, in 2020, Germany’s total multilateral funding for sexual & reproductive and family planning was around USD 121.85 million, an increase of about 65% from 2019. Furthermore, agencies, such as USAID run reproductive health & family planning programs in more than 30 countries, including South Africa & other African countries, where there is a high unmet need for contraception. However, there are various complications and adverse effects of prolonged use of contraceptives, which lead to an increase in the adoption of traditional contraceptive methods.
Long-term severe adverse effects of oral contraceptive pills, such as stroke, blood clots, decreased libido, vaginal discharge, and increased risk of breast cancer, may limit usage and lead to banning by regulatory agencies. Such factors could hamper the market growth during the forecast period. A few key products in the market are Xgeva, Evista, Prolia, Zometa, Mirena, Reclast/Aclasta, NuvaRing, Minastrin 24 Fe, Forteo, Actonel, Premarin, and Ortho Tri-Cy Lo (28). The market for NuvaRing declined by 3% in 2019 and 73% in 2020 primarily due to the introduction of generics following the patent expiry in 2018 in the U.S.
The contraceptives segment held the highest market share of more than 33.00% of the global revenue in 2021 due to increased awareness about family planning and rapid technological advancements in contraception. In addition, favorable government regulations in countries, such as the U.S., coupled with the growing awareness about various contraceptive methods are projected to accelerate the demand for contraceptives. For instance, the U.S. federal law mandates that all female-controlled contraceptive methods are covered under insurance without any out-of-pocket costs for patients.

  Universities in USA

  • Downstate Medical Center, USA
  • UAMS Medical Center, USA
  • North-western State University, USA
  • Frontier Nursing University, USA
  • The University of Pennsylvania School of Nursing, USA
  • Duke University School of Nursing, USA
  • MGH Institute of Health Professions, USA

Universities in Dubai

  • UNIVERSITY OF WOLLONGONG, DUBAI
  • GULF MEDICAL UNIVERSITY (GMU)
  • HAMDAN BIN MOHAMMED SMART UNIVERSITY
  • MOHAMMED BIN RASHID UNIVERSITY OF MEDICINE AND HEALTH SCIENCES (MBRU)
  • United Arab Emirates University
  • University of Sharjah
  • Gulf Medical University

Societies and Associations:

  • American College of Obstetricians and Gynaecologists
  • International Society for the Study of Women's Sexual Health
  • National Women's Health Network
  • Women's Health Initiative
  • International Society for Women's Health and Gender-Based Medicine
  • Women's Health Australia
  • Society for Women's Health Research
  • Women's Health and Education Center
  • European Society of Contraception and Reproductive Health

Meetings International is announcing the Young Scientist Awards through 2nd Annual Congress on Midwifery and Women`s Health will be held during October 22-23, 2024 in Paris, France. 
Women`s Health 2024 and upcoming conferences will recognize participants who have significantly added value to the scientific community of Women`s Health 2023 and provide them with outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researchers by meeting experts to exchange and share their experiences at our International Conferences.

Eligibility:
Young Scientists, faculty members, post-doctoral fellows, Ph.D. scholars, and bright Final Year MSc and M.Phil. Candidates. Persons from Scientific Industry can also participate.
Benefits: The Young Scientist Feature is a platform to promote young researchers in their respective areas by giving them a chance to present their achievements and future perspectives.

  • Acknowledgment as YRF Awardee
  • Promotion on the conference website, Young Researcher Awards, and certificates
  • Link on the conference website
  • Recognition on Meetings Int. Award Page
  • Chances to coordinate with partners around the world
  • Research work can be published in the relevant journal without any publication fee

Criteria:

  • All presented abstracts will automatically be considered for the Award.
  • All the presentations will be evaluated in the conference venue
  • All the awards will be selected by the judges of the award category
  • The winners of the Young Scientist Award will receive an award certificate.
  • The awards will be assessed as far as plan and format, intelligence, argumentation and approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

  • All submissions must be in English.
  • The topic must fit into the scientific sessions of the conference
  • Each individual participant is allowed to submit a maximum of 2 papers
  • An abstract must be submitted online as per the given abstract template
  • Abstracts must be written in Times New Roman and the font size will be 12
  • The abstract must contain a title, name, affiliation, country, speakers biography, recent photograph, image, and reference

Conditions of Acceptance:
To receive the award, the awardees must submit the presentation for which the award is given, for publication on the website, along with the author's permission. Failure to submit the PPT and permission within the designated timeframe will result in the forfeiture of the award.
Award Announcements:
The official announcement of the recipients will occur after the completion of the  Women`s Health  Conference.

Meetings International has always been at the forefront to support and encourage scientific and techno researchers to march forward with their research work. Annual congress on Midwifery and Women’s Health offers various awards as reorganization to exceptional researcher and their research work. We invite all enthusiastic researchers from all around the world to join us for the 2nd Annual congress on Midwifery and Women’s Health scheduled in October 22-23, 2024 in Paris, France.

Eminent Keynote Speaker Award:
Women’s Health 2024 will confer the Model Keynote Speaker Award to the researchers who have spent a considerable time of their academic life on the research related to the conference topic. The Keynote speaker award is for the researchers/speakers who have done all the hard work behind the scene. It will be a small clap for their dedication and hard work

Outstanding Speaker Award:
Women’s Health 2024 will bestow a model speaker award to those researchers who have made a significant contribution to the conference topic during their research period as well as presented the research topic in an impressive way in the oral presentation during the summit. It will be an apt appreciation from the Jury as well as from the delegates. The award they receive will motivate them to march forward with the research work

Model Organizing Committee Member Award:
Women’s Health 2024 will take this opportunity to facilitate eminent experts from this field with the model Organizing Committee Member award for their phenomenal contribution to society through their academic research. This will be a trivial but significant reorganization of their dedication and discipline

Promising Young Researcher Award:
The motive of this Award during the Women’s Health 2024 is to appreciate the research work of the budding young researcher who is continuing their research work to create a better society. The award will provide them with a tremendous amount of encouragement to keep moving forward

Educative Poster Award:
The educative poster award for the Women’s Health 2024 will be an endorsement for those who wish to display their research paper through a poster and will act as a guiding force for those researchers. The award will be presented to the most informative and educative research poster

Criteria:

  • All presented abstracts will automatically be considered for the Award.
  • All the presentations will be evaluated in the conference venue.
  • All the awards will be selected by the judges of the award category.
  • The winners will be formally announced during the closing ceremony.
  • The winners of the Poster Award will receive an award certificate.
  • The awards will be assessed as far as plan and format, intelligence, argumentation and approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and significant impression

Guidelines:

  • All submissions must be in English.
  • The topic must fit into the scientific sessions of the conference.
  • Each individual participant is allowed to submit a maximum of 2 papers.
  • The abstract must be submitted online as per the given abstract template.
  • Abstracts must be written in Times New Roman and the font size will be 12.
  • An abstract must contain a title, name, affiliation, country, speaker’s biography, recent photograph, image, and reference.
  • Each poster should be approximately 1x1 M long. The title, contents, and the author’s information should be clearly visible from a distance of 1-2 feet.
  • Reproductive Health
  • Hormone Replacement Therapy (HRT)
  • Womens Oncology
  • Menstrual Cycle & Menopause
  • Effect of Drugs on Pregnancy
  • Abortion and Mental Health
  • Mother and Child Care
  • Gynecology & Obstetrics
  • Breastfeeding and Brest cancer
  • Pregnancy and pre/post-natal care
  • Infertility and art
  • PCOD and PCOS

4 Organizing Committee Members

Media Partners & Collaborations

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner